Cargando…

八例先天性角化不良伴骨髓衰竭患儿的临床特征及基因分析

OBJECTIVE: To summary clinical and genetic features of childhood dyskeratosis congenital (DC) patients with bone marrow failure. METHODS: The clinical data of 8 DC patients with bone marrow failure diagnosed between September 2010 and September 2015 were collected. Whole exons with flanking regions...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342957/
https://www.ncbi.nlm.nih.gov/pubmed/27033759
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.03.008
_version_ 1783555646976688128
collection PubMed
description OBJECTIVE: To summary clinical and genetic features of childhood dyskeratosis congenital (DC) patients with bone marrow failure. METHODS: The clinical data of 8 DC patients with bone marrow failure diagnosed between September 2010 and September 2015 were collected. Whole exons with flanking regions of the 16 telomere-related genes, including DKC1, TERC, TERT, NOP10, NHP2, TINF2 and so on, were analyzed by next generation sequence. RESULTS: Six males and two females were included, with a median age of 42(15–60) months. The median blood cell count at onset were as follow: WBC 3.99 (1.26–5.44) × 10(9)/L, ANC 1.11 (0.38–2.15) × 10(9)/L, RBC 2.45 (0.37–3.56) × 10(12)/L, HGB 82.5(15–127) g/L, PLT 27 (2–112) ×10(9)/L. Hypoplastic or marked hypoplastic bone marrow were seen in 6 patients. DKC1 mutiaton were indentified in 3 patients: one c.961C>A mutation, and two c.1058C>T mutation. TINF2 mutations were identified in 4 patients: c.849delC, c.844C>T, c.811C>T, c.862T>A combined c.871delA. One patient had TINF2 mutation c.848C>A combined TERT mutation c.1138C>T. DKC1 c.961C>A mutation, TINF2 c.849delC mutation and TINF2 c.871delA mutaion were not reported so far. 5 of 7 patients got better after androgen administration. During follow-up, one patient died of serious infection, the other seven patients continued the treatment. CONCLUSION: TINF2 and DKC1 mutations were the main genetic phenotypes in childhood DC with marrow failure patients. Androgen is effetive in some cases.
format Online
Article
Text
id pubmed-7342957
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-73429572020-07-16 八例先天性角化不良伴骨髓衰竭患儿的临床特征及基因分析 Zhonghua Xue Ye Xue Za Zhi 论著 OBJECTIVE: To summary clinical and genetic features of childhood dyskeratosis congenital (DC) patients with bone marrow failure. METHODS: The clinical data of 8 DC patients with bone marrow failure diagnosed between September 2010 and September 2015 were collected. Whole exons with flanking regions of the 16 telomere-related genes, including DKC1, TERC, TERT, NOP10, NHP2, TINF2 and so on, were analyzed by next generation sequence. RESULTS: Six males and two females were included, with a median age of 42(15–60) months. The median blood cell count at onset were as follow: WBC 3.99 (1.26–5.44) × 10(9)/L, ANC 1.11 (0.38–2.15) × 10(9)/L, RBC 2.45 (0.37–3.56) × 10(12)/L, HGB 82.5(15–127) g/L, PLT 27 (2–112) ×10(9)/L. Hypoplastic or marked hypoplastic bone marrow were seen in 6 patients. DKC1 mutiaton were indentified in 3 patients: one c.961C>A mutation, and two c.1058C>T mutation. TINF2 mutations were identified in 4 patients: c.849delC, c.844C>T, c.811C>T, c.862T>A combined c.871delA. One patient had TINF2 mutation c.848C>A combined TERT mutation c.1138C>T. DKC1 c.961C>A mutation, TINF2 c.849delC mutation and TINF2 c.871delA mutaion were not reported so far. 5 of 7 patients got better after androgen administration. During follow-up, one patient died of serious infection, the other seven patients continued the treatment. CONCLUSION: TINF2 and DKC1 mutations were the main genetic phenotypes in childhood DC with marrow failure patients. Androgen is effetive in some cases. Editorial office of Chinese Journal of Hematology 2016-03 /pmc/articles/PMC7342957/ /pubmed/27033759 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.03.008 Text en 2016年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 论著
八例先天性角化不良伴骨髓衰竭患儿的临床特征及基因分析
title 八例先天性角化不良伴骨髓衰竭患儿的临床特征及基因分析
title_full 八例先天性角化不良伴骨髓衰竭患儿的临床特征及基因分析
title_fullStr 八例先天性角化不良伴骨髓衰竭患儿的临床特征及基因分析
title_full_unstemmed 八例先天性角化不良伴骨髓衰竭患儿的临床特征及基因分析
title_short 八例先天性角化不良伴骨髓衰竭患儿的临床特征及基因分析
title_sort 八例先天性角化不良伴骨髓衰竭患儿的临床特征及基因分析
topic 论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342957/
https://www.ncbi.nlm.nih.gov/pubmed/27033759
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.03.008
work_keys_str_mv AT bālìxiāntiānxìngjiǎohuàbùliángbàngǔsuǐshuāijiéhuànérdelínchuángtèzhēngjíjīyīnfēnxī
AT bālìxiāntiānxìngjiǎohuàbùliángbàngǔsuǐshuāijiéhuànérdelínchuángtèzhēngjíjīyīnfēnxī
AT bālìxiāntiānxìngjiǎohuàbùliángbàngǔsuǐshuāijiéhuànérdelínchuángtèzhēngjíjīyīnfēnxī
AT bālìxiāntiānxìngjiǎohuàbùliángbàngǔsuǐshuāijiéhuànérdelínchuángtèzhēngjíjīyīnfēnxī
AT bālìxiāntiānxìngjiǎohuàbùliángbàngǔsuǐshuāijiéhuànérdelínchuángtèzhēngjíjīyīnfēnxī
AT bālìxiāntiānxìngjiǎohuàbùliángbàngǔsuǐshuāijiéhuànérdelínchuángtèzhēngjíjīyīnfēnxī
AT bālìxiāntiānxìngjiǎohuàbùliángbàngǔsuǐshuāijiéhuànérdelínchuángtèzhēngjíjīyīnfēnxī
AT bālìxiāntiānxìngjiǎohuàbùliángbàngǔsuǐshuāijiéhuànérdelínchuángtèzhēngjíjīyīnfēnxī
AT bālìxiāntiānxìngjiǎohuàbùliángbàngǔsuǐshuāijiéhuànérdelínchuángtèzhēngjíjīyīnfēnxī
AT bālìxiāntiānxìngjiǎohuàbùliángbàngǔsuǐshuāijiéhuànérdelínchuángtèzhēngjíjīyīnfēnxī
AT bālìxiāntiānxìngjiǎohuàbùliángbàngǔsuǐshuāijiéhuànérdelínchuángtèzhēngjíjīyīnfēnxī
AT bālìxiāntiānxìngjiǎohuàbùliángbàngǔsuǐshuāijiéhuànérdelínchuángtèzhēngjíjīyīnfēnxī
AT bālìxiāntiānxìngjiǎohuàbùliángbàngǔsuǐshuāijiéhuànérdelínchuángtèzhēngjíjīyīnfēnxī
AT bālìxiāntiānxìngjiǎohuàbùliángbàngǔsuǐshuāijiéhuànérdelínchuángtèzhēngjíjīyīnfēnxī